Viatris Inc: Drug Recall
Recall #D-1542-2022 · 09/21/2022
Class II: Risk
Recall Details
- Recall Number
- D-1542-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Viatris Inc
- Status
- Terminated
- Date Initiated
- 09/21/2022
- Location
- Canonsburg, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,931 cartons
Reason for Recall
Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.
Product Description
Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A
Distribution Pattern
Nationwide in the USA
Other Recalls by Viatris Inc
- Class II: Risk 12/23/2024
- Class II: Risk 12/23/2024
- Class II: Risk 11/18/2024
- Class II: Risk 11/18/2024
- Class II: Risk 11/18/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.